EI-1071
Alzheimer's disease, ALS, Parkinson's disease
Phase 1/2Active
Key Facts
Indication
Alzheimer's disease, ALS, Parkinson's disease
Phase
Phase 1/2
Status
Active
Company
About Elixiron Immunotherapeutics
Taiwan biotech delivering precision immunotherapies for neurodegeneration, autoimmunity, and cancer via mRNA and antibody platforms.
View full company profile